Protein kinase inhibitors: Current strategies and future prospects
Keywords: apoptosis, crystal, inhibition, enzyme, weight, transcription, binding, kidney, protein, proliferation, cell, design, structure, carcinoma, transition, cancer, metabolism, site, humans, transduction, lung, leukemia, human, inhibitor, signal, kinases, drug, molecular, inhibitors, kinase, angiogenesis, breast, genetic, chronic, gefitinib, small, editorial, tracer, imatinib, sunitinib, nilotinib, myeloid, priority, conformational, dasatinib, journal, effect, non, erlotinib, sorafenib, lapatinib
Abstract
[No abstract available]
Más información
Título de la Revista: | CURRENT PHARMACEUTICAL DESIGN |
Volumen: | 18 |
Número: | 20 |
Editorial: | BENTHAM SCIENCE PUBL LTD |
Fecha de publicación: | 2012 |
Página de inicio: | 2851 |
Página final: | 2851 |
URL: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84861738100&partnerID=40&md5=a8500ae3105f475628ec3210c037ddf5 |